AU Patent

AU2003246603A1 — Process for providing a stable crystalline form of salbutamol

Assigned to Boehringer Ingelheim Pharma GmbH and Co KG · Expires 2004-02-02 · 22y expired

What this patent protects

Patent listed against null.

Drugs covered by this patent

Patent Metadata

Patent number: AU2003246603A1
Jurisdiction: AU
Classification: —
Expires: 2004-02-02
Drug substance claim: No
Drug product claim: No
Assignee: Boehringer Ingelheim Pharma GmbH and Co KG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.